270 related articles for article (PubMed ID: 28246612)
1. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
3. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
Li Q; Feng L; Li J; Chen Q
Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
[TBL] [Abstract][Full Text] [Related]
4. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
5. Urine AQP5 is a potential novel biomarker of diabetic nephropathy.
Lu Y; Chen L; Zhao B; Xiao Z; Meng T; Zhou Q; Zhang W
J Diabetes Complications; 2016 Jul; 30(5):819-25. PubMed ID: 27103565
[TBL] [Abstract][Full Text] [Related]
6. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
Aldemir O; Turgut F; Gokce C
Ren Fail; 2017 Nov; 39(1):597-601. PubMed ID: 28805547
[TBL] [Abstract][Full Text] [Related]
7. Urinary proteomics for early diagnosis in diabetic nephropathy.
Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
[TBL] [Abstract][Full Text] [Related]
8. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients.
Jin J; Ku YH; Kim Y; Kim Y; Kim K; Lee JY; Cho YM; Lee HK; Park KS; Kim Y
Exp Diabetes Res; 2012; 2012():168602. PubMed ID: 22536212
[TBL] [Abstract][Full Text] [Related]
9. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
10. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
Zubiri I; Posada-Ayala M; Sanz-Maroto A; Calvo E; Martin-Lorenzo M; Gonzalez-Calero L; de la Cuesta F; Lopez JA; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
J Proteomics; 2014 Jan; 96():92-102. PubMed ID: 24211404
[TBL] [Abstract][Full Text] [Related]
11. Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy.
Feng Y; Zhong X; Ni HF; Wang C; Tang TT; Wang LT; Song KY; Tang RN; Liu H; Liu BC; Lv LL
J Transl Med; 2021 Aug; 19(1):355. PubMed ID: 34404433
[TBL] [Abstract][Full Text] [Related]
12. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
13. Urinary AQP5 is independently associated with eGFR decline in patients with type 2 diabetes and nephropathy.
Gao C; Zhang W
Diabetes Res Clin Pract; 2019 Sep; 155():107805. PubMed ID: 31377226
[TBL] [Abstract][Full Text] [Related]
14. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
[TBL] [Abstract][Full Text] [Related]
15. Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy.
Chen J; Zhang WW; Chen KH; Lin LR; Dai HZ; Li KL; Zhang JG; Zheng LQ; Fu BQ; He YN
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F273-F281. PubMed ID: 28356293
[TBL] [Abstract][Full Text] [Related]
16. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
[TBL] [Abstract][Full Text] [Related]
17. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
19. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
Fawzy MS; Abu AlSel BT
J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
